A practical and applicable desensitization scheme for ciprofloxacin with a glass of water

Main Article Content

Zeynep Yegin Katran https://orcid.org/0000-0002-6858-6824
İsmet Bulut
Feyza Yegin
Mustafa Katran

Keywords

desensitization, ciprofloxacin, quinolone

Abstract

Desensitization is an immunological process that creates temporary tolerance to a drug, which disappears once treatment is discontinued. Ciprofloxacin is a commonly used antibiotic, particularly for chronic lung diseases, yet there are very few desensitization protocols for it. Two ciprofloxacin desensitization schemes were developed a long time ago. However, these protocols are multistep, time-consuming processes, due to which a new protocol is required. We would like to present the practical oral desensitization protocol that we use. We included two patients with cystic fibrosis and bronchiectasis who required ciprofloxacin due to the presence of Pseudomonas aeruginosa in their sputum cultures. The desensitization process was successful and well-tolerated. This protocol is important because it addresses a significant gap in the literature.

Abstract 122 | PDF Downloads 100 HTML Downloads 0 XML Downloads 1

References

1 Castells MC, Solensky R. Rapid drug desensitization for immediate hypersensitivity reactions. [cited 2023 Jun 26]. Available from: https://www.uptodate.com/contents/rapid-drug-desensitization-for-immediate-hypersensitivity-reactions

2 Kang SY, Seo J, Kang HR. Desensitization for the prevention of drug hypersensitivity reactions. Korean J Intern Med. 2022;37(2):261–70. 10.3904/kjim.2021.438

3 Lee CW, Matulonis UA, Castells MC. Carboplatin hypersensitivity: A 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol. 2004;95(2):370–6. 10.1016/j.ygyno.2004.08.002

4 Gea-Banacloche JC, Metcalfe DD. Ciprofloxacin desensitization. J Allergy Clin Immunol. 1996;97(6):1426–7. 10.1016/s0091-6749(96)70218-x

5 Lantner RR. Ciprofloxacin desensitization in a patient with cystic fibrosis. J Allergy Clin Immunol. 1995;96(6 Pt 1):1001–2. 10.1016/s0091-6749(95)70240-7

6 Doña I, Moreno E, Pérez-Sánchez N, Andreu I, Hernández Fernandez de Rojas D, Torres MJ. Update on quinolone allergy. Curr Allergy Asthma Rep. 2017;17(8):56. 10.1007/s11882-017-0725-y